Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
Clinical trial NCT00232102 · COMPLETED
Trial details
- NCT number
- NCT00232102
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Enrollment
- 423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.